This inventor holds 6 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Sgx Pharmaceuticals, Inc., Selexagen Therapeutics, Inc.. Active years: 2009-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2015
Title: The Innovative Contributions of Pierre-Yves Bounaud
Introduction
Pierre-Yves Bounaud is a notable inventor based in San Diego, CA, with a significant portfolio of six patents. His work primarily focuses on pharmaceutical innovations that address critical health issues in both human and veterinary medicine.
Latest Patents
Among his latest patents, Bounaud has developed compounds for the inhibition of Hedgehog signaling, which are essential in treating various diseases and disorders. Additionally, he has created bicyclic triazole protein kinase modulators, which offer new methods for treating diseases mediated by kinase activity.
Career Highlights
Bounaud has made substantial contributions to the field of pharmaceuticals through his work at Sgx Pharmaceuticals, Inc. and Selexagen Therapeutics, Inc. His innovative approaches have paved the way for advancements in medical treatments.
Collaborations
Bounaud has collaborated with notable professionals in the industry, including William D. Arnold and Andreas Gosberg. These partnerships have further enhanced his research and development efforts.
Conclusion
Pierre-Yves Bounaud's contributions to pharmaceutical innovation demonstrate his commitment to improving health outcomes through his inventive work. His patents reflect a deep understanding of complex biological processes and a dedication to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile